Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2026-02-04 @ 8:07 AM
Study NCT ID:
NCT03218995
Status:
COMPLETED
Last Update Posted:
2021-12-09
First Post:
2017-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
Sponsor:
Sarepta Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
4658-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None